{
  "completed": [
    0,
    1,
    2,
    3,
    4,
    5,
    6,
    7,
    8,
    9
  ],
  "results": [
    {
      "example_idx": 0,
      "dataset_id": "1511",
      "question": "What is a lockdown?",
      "ground_truth_answer": "A lockdown is the implementation of strict restrictions and measures to limit people's movement and activities in order to control the spread of infections, such as the one mentioned in the given context.",
      "generated_response": "<think>\nOkay, the user is asking, \"What is a lockdown?\" and the context provided seems to be about estimating infections and the impact of non-lockdown measures. Wait, the context titles are all \"Estimating the number of infections and the impact of non-\" followed by \"Lockdown\" each time. The passage mentions \"banned Implemented with lockdown.57 24/3/2020\". Hmm, maybe there's a typo or formatting issue here.\n\nFirst, I need to figure out what the context is actually saying. The titles suggest that the study is about the impact of not having a lockdown. The passage snippet says \"banned Implemented with lockdown.57 24/3/2020\". That part is a bit confusing. Maybe \"banned\" is a typo for \"ban\" or \"implemented\"? The date 24/3/2020 is March 24, 2020, which is around when many countries started lockdowns due to the pandemic.\n\nSince the user is asking for the definition of a lockdown, I should provide a general answer based on common knowledge, but also check if the context gives any specific information. The context seems to discuss the impact of lockdowns on infections, so maybe the answer should mention that a lockdown is a public health measure to restrict movement to control disease spread. However, the context might not have enough clear information to define it, so I should rely on general knowledge but also note that the context is about the effects of lockdowns versus non-lockdowns.\n\nWait, the user's instruction says to answer based on the provided context. The context is a bit unclear, but the titles and the mention of lockdowns in the context imply that a lockdown is a measure taken to reduce infections. The passage snippet mentions \"banned Implemented with lockdown.57 24/3/2020\" which might be a typo. Maybe it's supposed to say that a lockdown was implemented on March 24, 2020. If that's the case, the context is about the implementation of lockdowns and their impact on infection numbers.\n\nSo, putting it all together, a lockdown is a public health intervention where movement is restricted to prevent the spread of a disease, as discussed in the context of estimating infections and the impact of not having such measures. The context's mention of lockdown implementation on a specific date supports that definition",
      "retrieved_chunks": [
        "Title: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: Lockdown\n\nTitle: Estimating the number of infections and the impact of non-\nPassage: banned Implemented with lockdown.57 24/3/2020"
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 0.0,
      "binary_pred": 0,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 1,
      "dataset_id": "1085",
      "question": "What complications are associated with CHIKV?",
      "ground_truth_answer": "Complications associated with CHIKV include respiratory failure, cardiovascular decompensation, meningoencephalitis, severe acute hepatitis, severe cutaneous effects, other central nervous system problems, and kidney failure.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about the complications associated with CHIKV, which I know is Chikungunya virus. Let me look at the provided context to find the answer.\n\nFirst, the passage mentions that mothers can transmit CHIKV to their babies during the perinatal period, and this is linked to high morbidity. So, high morbidity is a complication. Then, it says that by day 4 of life, all neonates were symptomatic with common CHIKF symptoms. CHIKF is probably Chikungunya Fever. The next part says six neonates had CHIKV and developed meningoencephalitis. Wait, the original text says \"mengoencephalitis\"\u2014maybe a typo for meningoencephalitis? That's a combination of meningitis and encephalitis, which are serious neurological complications.\n\nAnother part reports nineteen cases of neonatal infection from mothers with intrapartum viremia, leading to encephalitis due to vertical transmission. So encephalitis is another complication. Also, in the La Reunion Island epidemic, mothers infected long before delivery had three fetal deaths. Fetal death is a complication too.\n\nPutting it all together, the complications include meningoencephalitis, encephalitis, high morbidity, and fetal death. The answer should list these. Let me check if there's anything else. The common symptoms are mentioned, but the question is about complications, so the severe outcomes like the neurological issues and fetal death are the key points here.\n</think>\n\nThe complications associated with CHIKV (Chikungunya virus) include **meningoencephalitis**, **encephalitis**, and **fetal death**. These complications arise from vertical transmission during the perinatal period, leading to severe neurological conditions in neonates and adverse pregnancy outcomes. Additionally, infected neonates exhibit high morbidity and symptomatic CHIKF (Chikungunya Fever) within days of birth.",
      "retrieved_chunks": [
        "Passage: and complications.",
        "discovered that mothers could transmit CHIKV to their progeny during the perinatal period , and it is associated with a high degree of morbidity. By mean Day 4 of life, all of the neonates were symptomatic for CHIKV, exhibiting common CHIKF symptoms. Six neonates were confirmed to have contracted CHIKV and developed mengoencephalitis.",
        "reported nineteen cases of neonatal infection associated with intrapartum maternal viremia that progressed to develop encephalitis owing to vertical transmission from infected mothers .",
        "Of those mothers who, during the La Reunion Island epidemic, were infected long before delivery, only three fetal deaths were reported .",
        "Passage: A similar study by Gerardin et al."
      ],
      "computed_relevance": 0.7142857142857143,
      "computed_utilization": 0.7142857142857143,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2,
      "gt_utilization": 0.2,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 2,
      "dataset_id": "1248",
      "question": "What does Clade A contain?",
      "ground_truth_answer": "Clade A contains 1,889 viruses from 34 countries collected from 2010 to the present.",
      "generated_response": "<think>\nOkay, let's try to figure out what Clade A contains based on the provided context. The user is asking about Clade A, but looking through the passages, I don't see any mention of a clade labeled \"A.\" The passages talk about clades like 1B, 1A.1, 1A.1.1, 1C.2, and others. The titles and passages discuss different lineages and clades within the H1 hemagglutinin genes of swine influenza A viruses.\n\nThe first passage mentions the 1B human seasonal lineage and refers to Table 3 for within and between-clade APDs. Then there's a mention of exceptions for 1A.1 and 1A.1.1. Another passage talks about the 1C lineage with clades in China and South Korea. The last passage refers to seven clades influenced by surveillance in the US, Canada, and the 2009 pandemic. \n\nSince there's no mention of Clade A specifically, maybe the user is referring to a clade that's part of these lineages but labeled differently. However, the answer should be based on the given context. Since the context doesn't mention Clade A, the answer would be that there's no information provided about Clade A in the given passages. Alternatively, maybe there's a mislabeling or a typo, but based on the text provided, Clade A isn't discussed. Therefore, the answer is that the context doesn't contain information about Clade A.\n</think>\n\nThe provided context does not mention or describe a specific \"Clade A.\" The passages discuss clades such as **1B**, **1A.1**, **1A.1.1**, **1C**, and **1C.2**, which are part of phylogenetic lineages of swine influenza A virus H1 hemagglutinin genes. However, there is no reference to a clade explicitly labeled \"A\" in the given text. The nomenclature used in the context follows a numerical and hierarchical system (e.g., 1A.1, 1C.2) rather than alphabetical labels like \"Clade A.\" \n\n**Answer:** The context does not provide information about \"Clade A,\" as it focuses on numerically designated clades (e.g., 1A.1, 1B, 1C",
      "retrieved_chunks": [
        "Each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade, although some minor exceptions were made when all other clade-defining criteria were met and mitigating circumstances supported the exception.",
        "For the most part, each clade had an APD of \u03fe7% from other clades and an APD of \u03fd7% within the clade.",
        "The one within-clade exception in this lineage was 1C.2 , which had multiple monophyletic\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: The 1B human seasonal lineage within-and between-clade APDs are presented in Table 3 .",
        "Within-clade exceptions were made for the first-order 1A.1 and the extensive 1A.1.1 second-order clade\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: Clade designations for 1C swine lineage. The 1C lineage consisted of 315 viruses from 14 countries collected from 2010 to the present in China and South Korea. Avian H1 HA sequences were generally restricted to two monophyletic clades distinct from, but sister to, the 1C swine viruses: these HA sequences were defined as \"Other-Avian.\" The within-and between-clade APDs are presented in Table 4 .",
        "The exception to the between-clade threshold was associated with clades\n\nTitle: A Phylogeny-Based Global Nomenclature System and Automated Annotation Tool for H1 Hemagglutinin Genes from Swine Influenza A Viruses\nPassage: were placed into seven clades. The numerically dominant clades reflected intensive surveillance in the United States , investigator sequencing efforts in Canada , and the rapid dissemination of the 2009 H1N1 pandemic virus across global swine populations ."
      ],
      "computed_relevance": 0.375,
      "computed_utilization": 0.375,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 1.0,
      "gt_utilization": 0.041666666666666664,
      "gt_completeness": 0.041666666666666664,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 3,
      "dataset_id": "1696",
      "question": "How do the S1 subunits compare with that of SARS-likeCOV and human SARS-COV?",
      "ground_truth_answer": "The S1 subunit of 2019-nCoV shares around 70% identity with those of two bat SARS-like CoVs and human SARS-CoV.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how the S1 subunits of 2019-nCoV compare to those of SARS-like CoVs and human SARS-CoV. \n\nFirst, I need to look at the provided context. The passage mentions that the S1 subunit of 2019-nCoV shares around 70% identity with the two bat SARS-like CoVs and human SARS-CoV. The key point here is the percentage of identity. The S2 subunit is highly conserved at 99%, but the S1 is lower at 70%. \n\nThe context also notes that most bat SARS-related CoVs have deletions in the spike receptor binding domain (RBD) compared to human SARS-CoV. However, the core domain of the RBD is highly conserved. This might be relevant because the S1 subunit includes the RBD, which is crucial for binding to the host cell receptor.\n\nSo, putting this together: the S1 subunit of 2019-nCoV is less conserved compared to SARS-like CoVs and human SARS-CoV (70% identity), whereas the S2 subunit is more conserved (99%). The deletions in bat CoVs in the RBD area might affect the S1 subunit's structure or function, but the core RBD is still conserved. \n\nThe answer should highlight the 70% identity for S1, contrast it with the higher S2 conservation, and mention the deletions in bat viruses but note the conserved core RBD. Also, since the question is about comparison with SARS-like CoVs and human SARS-CoV, I should make sure to specify that the 70% applies to both groups mentioned.\n</think>\n\nThe S1 subunit of 2019-nCoV shares approximately **70% identity** with the S1 subunits of both bat SARS-like CoVs and human SARS-CoV. While this indicates some conservation, it is significantly lower than the **99% identity** observed in the S2 subunit. Notably, the **core domain of the receptor-binding domain (RBD)** within the S1 subunit is highly conserved across these viruses. However, most bat SARS-related CoVs (excluding 2019-nCoV and human",
      "retrieved_chunks": [
        "Unlike 2019-nCoV and human SARS-CoV, most known bat SARSr-CoVs have two stretches of deletions in the spike receptor binding domain when compared with that of human SARS-CoV.",
        "We found that the S2 subunit of 2019-nCoV is highly conserved and shares 99% identity with those of the two bat SARS-like CoVs and human SARS-CoV .",
        "Though the S1\n\nTitle: Genomic characterization of the 2019 novel human-pathogenic coronavirus isolated from a patient with atypical pneumonia after visiting Wuhan\nPassage: subunit of 2019-nCoV shares around 70% identity to that of the two bat SARS-like CoVs and human SARS-CoV ), the core domain of RBD are highly conserved ).",
        "The 2019-nCoV had the same SL6, SL7, and SL8 as SARS-CoV, and an additional",
        "The SL1, SL2, SL3, SL4, S5, SL5A, SL5B, and SL5C structures were similar among the 2019-nCoV, human SARS-CoV and the bat SARS-related ZC45. In the 2019-nCoV, part of the S5 found was inside Figure 7 Continued the orf1a/b , which was similar to SARS-CoV. In bat SARS-related CoV ZC45, the S5 was not found inside orf1a/b."
      ],
      "computed_relevance": 0.2857142857142857,
      "computed_utilization": 0.2857142857142857,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.12,
      "gt_utilization": 0.04,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 4,
      "dataset_id": "669",
      "question": "What is Bacillus subtilis?",
      "ground_truth_answer": "Bacillus subtilis is a species of bacteria that has been shown to be effective in the prevention and/or treatment of intestinal diseases such as diarrhea, colitis, irritable bowel syndrome, irritable bowel disease, and colorectal cancer. It is also a part of the normal intestinal microbiome and has been found in the healthy human gastrointestinal tract. Bacillus subtilis produces surfactins, fengycins, and iturins, which have antimicrobial and antiviral properties.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking, \"What is Bacillus subtilis?\" and I need to answer based on the provided context.\n\nFirst, I'll look through the context given. There are three passages here. The first one mentions that Bacillus spp. subtilis produces surfactins, fengycins, and iturins in a specific ratio. The second passage talks about how Bacillus and Lactobacillus species are found in fermented foods and used in probiotics. The third passage states that Bacillus species, unlike Lactobacillus, weren't considered part of the normal intestinal microbiome but are found in feces. It also mentions that B. subtilis helps retain gut barrier integrity, reduces endotoxins, and decreases gut inflammation.\n\nSo, putting this together, Bacillus subtilis is a species of Bacillus that produces certain compounds (surfactins, etc.), is used in probiotics, and has beneficial effects on the gut. The answer should include its role in producing those substances, its use in probiotics, and its benefits for gut health. Also, note that it's found in fermented foods and the environment near decomposing plants. I need to make sure the answer is concise and covers these points without adding extra information not in the context.\n</think>\n\nBacillus subtilis is a species of the Bacillus genus known for producing bioactive compounds such as surfactins, fengycins, and iturins (in a 6:37:57 ratio). It is found in environments like decomposing plant material and has been historically associated with fermented foods and probiotics. While not traditionally considered part of the normal intestinal microbiome, *B. subtilis* contributes to gut health by maintaining gut barrier integrity, reducing endotoxin levels, and decreasing inflammation. It is also utilized in commercial probiotics (e.g., Biosubtyl, BioSpora) and food fermentation processes.",
      "retrieved_chunks": [
        "Bacillus spp.",
        "subtilis produces surfactins, fengycins and iturins in a ratio of 6:37:57 .",
        "In environment, the vegetative forms of Bacillus are present usually near decomposing plants and in their\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: B.",
        "subtilis plays a\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: Historically, species of Lactobacillus and Bacillus are found in the traditional fermented food products possessing beneficial properties for the intestinal function and are widely used as components of commercially available probiotics: DE111 , Enterogermina , Biosubtyl , Biosporin , BioSpora , Blicheni and Zhengchangsheng , GanedenBC 30 , Lactobacterin , HOWARU or DR20 , Yakult , PCC . In food industry, lactobacilli are applied as starter cultures in the production of fermented milk products, cheese, sausages, bread, kimchi, pickles, and yogurts, the latter accounting for the largest share of sales . The administration of probiotics has been shown to favorably\n\nTitle: Secretome of Intestinal Bacilli: A Natural Guard against Pathologies\nPassage: For a long time, the representatives of Bacillus genus, unlike the species of Lactobacillus, were not considered as a part of the normal intestinal microbiome. Being isolated from feces, Bacillus spp.",
        "subtilis also retained gut barrier integrity, decreased the endotoxin concentration and reduced gut inflammation Bene et al., 2017) ."
      ],
      "computed_relevance": 0.5,
      "computed_utilization": 0.5,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.4090909090909091,
      "gt_utilization": 0.18181818181818182,
      "gt_completeness": 0.3333333333333333,
      "gt_adherence": 0.0,
      "binary_pred": 1,
      "binary_gt": 0,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 5,
      "dataset_id": "81",
      "question": "What past research has been done on severe, single-wave pandemics?",
      "ground_truth_answer": "The given passages do not specifically mention past research on severe, single-wave pandemics. However, they do reference research on pandemic strains, influenza spread, and pandemic severity categories, as well as the origins and circulation of specific pandemic influenza strains.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking about past research on severe, single-wave pandemics. I need to look through the provided contexts to find relevant information.\n\nFirst, looking at the first context titled \"The origins of the great pandemic,\" it mentions the 1889 pandemic with three major waves, but the user is interested in single-wave pandemics. However, there's a mention of the 1918 pandemic's herald waves possibly stretching back to 1915. But the 1918 pandemic itself is known for having multiple waves, so maybe not directly relevant here. Still, the context talks about viruses circulating before the recognized pandemic, which might relate to understanding pandemic origins but not necessarily single-wave.\n\nNext, the second context about the 2009 pandemic in Hong Kong discusses convalescent plasma treatment and research on epidemiology, impact, and control. It mentions studies on pH1N1 but doesn't specify if it was a single wave. However, the third context titled \"On Temporal Patterns...\" refers to multi-wave epidemics using the Richards model. The 2009 pH1N1 pandemic is mentioned here, but again, the study is about multi-wave patterns. However, the user is asking about single-wave, so maybe the 2009 pandemic wasn't single-wave? Wait, I think the 2009 H1N1 was a single wave? Or was it multiple? I might need to recall, but since the context here talks about multi-wave, perhaps it's not the best example.\n\nThe fourth context is about economic analysis of mitigation strategies for five pandemic severity categories. It references studies using simulation models but doesn't specify if they're about single or multi-wave pandemics. The question is about research on severe, single-wave pandemics. The answer might be in the first context's mention of the 1889 pandemic having three waves, but the user wants single-wave. Maybe the 1918 pandemic's herald waves? But the 1918 was multi-wave. Hmm.\n\nWait, the first context says that the 1889 pandemic had three waves, but the user is looking for single-wave. Maybe there's another example. The third context mentions the 2009 pH1N1 pandemic and uses a model for multi-wave epidemics. But perhaps there's research on single-wave? The",
      "retrieved_chunks": [
        "Title: The origins of the great pandemic\nPassage: Because the 1889 pandemic unfolded with three major waves worldwide from 1889 to 1892 , with the 1892 wave being the most intense, at least on the East Coast of the USA, it seems worth considering whether so-called herald waves of the 1918 pandemic might have stretched back all the way to 1915. Viruses with identical or nearly identical genome sequences to those in the fall wave were circulating in early 1918 , at a time prior to the recognition of a new pandemic. It is perhaps not so great a leap to imagine that these viruses were related to\n\nTitle: The epidemiological and public health research response to 2009 pandemic influenza A(H1N1): experiences from Hong Kong\nPassage: of convalescent plasma to treat severe infections was shown to be feasible in a pandemic 57 and evidence of its effectiveness albeit from a small study should justify further studies.",
        "56 While we focused on research into the epidemiology, impact, and control of pH1N1, much important research on pH1N1 has been carried out in other areas outside the scope of our review.",
        "Also in contrast with those models,\n\nTitle: On Temporal Patterns and Circulation of Influenza Virus Strains in Taiwan, 2008-2014: Implications of 2009 pH1N1 Pandemic\nPassage: When there is more than one wave of infections, as in our current study, a variation of the Richards model can be utilized, which makes the distinction between two types of turning points ; one type which occurs at the peak incidence, and a second type which occurs in a multi-wave epidemic when the growth rate of the cumulative case number begins to increase again, indicating the beginning of the next wave.",
        "The current study extends upon the scope of these studies in several ways: five gradations of pandemic severity are considered, more combinations of interventions are considered, social distancing interventions of varying durations are considered, and probabilities of severe health outcomes for each severity category are based on fatality, hospitalization and ICU usage data as observed from the 2009 pandemic.",
        "To give two specific examples, local researchers confirmed the origins of the 2009 pandemic strain by comparison with a detailed local swine influenza surveillance program, 65 and performed important basic studies on pathogenesis. 66 Two sets of studies\n\nTitle: Economic analysis of pandemic influenza mitigation strategies for five pandemic severity categories\nPassage: Several related studies which also used individualbased simulation models of influenza spread coupled with costing models are those of those of Sander et al., Perlroth et al., Brown et al., and Andradottir et al."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 1.0,
      "computed_completeness": 0.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.26666666666666666,
      "gt_utilization": 0.26666666666666666,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 6,
      "dataset_id": "1564",
      "question": "How many reported viral pneumonia?",
      "ground_truth_answer": "The passage does not provide a specific number of reported viral pneumonia cases overall. However, it mentions 2744 confirmed cases of pneumonia with 2019-nCoV infection in China, and it also mentions 77 fatal cases of pandemic H1N1v 2009 infection.",
      "generated_response": "<think>\nOkay, let's try to figure out how many reported viral pneumonia cases there are based on the context provided. The user is asking for the number of reported viral pneumonia cases, so I need to look through each of the provided passages to see if they mention any numbers related to viral pneumonia.\n\nFirst, looking at the first passage titled \"Clinical review: Primary influenza viral pneumonia,\" it mentions bacterial co-infection in the 2009 H1N1 pandemic. It says that 29% of 77 fatal cases had concurrent bacterial pneumonia. But this is about bacterial co-infection, not the number of viral pneumonia cases directly. So maybe not the answer here.\n\nNext, the second passage is about pneumonia in adults with seasonal influenza in the US from 2005\u20132008. It notes that patients with pneumonia were more likely to receive antiviral therapy. But again, it's about treatment differences, not the count of cases.\n\nThird passage is about the 2019-nCoV (now known as COVID-19) pneumonia. The passage states that as of January 26, 2020, there were 2744 confirmed cases of pneumonia with 2019-nCoV infection in China. This seems like a direct mention of viral pneumonia cases caused by the novel coronavirus. The question is about \"reported viral pneumonia,\" so this might be the key number here. The 2744 confirmed cases would be viral pneumonia due to 2019-nCoV.\n\nThe fourth passage again talks about influenza attack rates during pandemics, giving examples like the 2009 H1N1. But it's about percentages and not actual numbers of cases. The other part mentions 51 cases cured and discharged, 5794 suspected cases, etc. However, the 51 discharged and 5794 suspected might be part of the same context as the 2744 confirmed cases from the third passage. But the question is about \"reported viral pneumonia,\" and the 2744 is specifically about confirmed cases of pneumonia with 2019-nCoV. The other numbers like 5794 suspected cases are not confirmed, so the confirmed cases would be the 2744.\n\nSo putting it all together, the answer is likely 2744 reported cases of viral pneumonia from",
      "retrieved_chunks": [
        "A total of confirmed cases were reported from Hong Kong, Macao and Taiwan of China:\n\nTitle: Clinical review: Primary influenza viral pneumonia\nPassage: Bacterial co-infection, though uncommonly reported in the early stages of the 2009 H1N1 pandemic, may be more prevalent than initially thought. A recent analysis of lung specimens from 77 fatal cases of pandemic H1N1v 2009 infection found a prevalence of concurrent bacterial pneumonia in 29% of these patients .",
        "Title: Pneumonia among adults hospitalized with laboratory-confirmed seasonal influenza virus infection\u2014United States, 2005\u20132008\nPassage: Patients with pneumonia ] were significantly more likely to receive influenza antiviral therapy than patients without pneumonia ; P <0.01].",
        "Title: A rapid advice guideline for the diagnosis and treatment of 2019 novel coronavirus (2019-nCoV) infected pneumonia (standard version)\nPassage: At 24:00 on 26 January 2020, the National Health Commission of the People's Republic of China has recorded a total of 2744 confirmed cases of pneumonia with 2019-nCoV infection from 30 provinces , including 461 severe cases and 80 deaths.",
        "Title: Clinical review: Primary influenza viral pneumonia\nPassage: age versus 6% to 9% of the adults 18 to 64 years of age and none of the children . Influenza attack rates during seasonal epidemics vary between 10% and 20% but can be much higher during pandemics. For example, an analysis of the pandemic 2009 H1N1 influenza A outbreak in La Gloria, Veracruz, found clinical attack rates of 29% in adults older than 15 years and 61% in children younger than 15 years of age .",
        "A total of 51 cases have been cured and discharged. At present, 5794 suspected cases were recorded, 32,799 with close contacts to the confirmed patients have been tracked, 583 people were released from medical observation that day, and 30,453 people were still undergoing medical observation."
      ],
      "computed_relevance": 0.2222222222222222,
      "computed_utilization": 0.8888888888888888,
      "computed_completeness": 1.0,
      "computed_adherence": 0.0,
      "gt_relevance": 0.125,
      "gt_utilization": 0.125,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 0,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 7,
      "dataset_id": "1247",
      "question": "How has most of the analysis of MERS-CoV genetics  been performed?",
      "ground_truth_answer": "Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction.",
      "generated_response": "<think>\nOkay, let's tackle this question. The user is asking how most of the analysis of MERS-CoV genetics has been performed. I need to look through the provided context to find the answer.\n\nLooking at the first passage, the first sentence says, \"Most of the analysis of MERS-CoV genetics has been performed using high throughput or 'deep' sequencing methods for complete genome deduction.\" That seems like the direct answer. The passage also mentions that MERS-CoV was the first to have such widespread use of deep sequencing for studying an emerging viral outbreak. \n\nI should check the other passages to make sure there's no conflicting information. The second passage talks about genetic recombination and subgenomic sequencing but doesn't contradict the first point. The third passage discusses genome analyses focusing on specific regions like the spike protein, but again, the method mentioned there isn't different from the first. The fourth passage emphasizes vigilance and data sharing but doesn't mention the analysis method. \n\nSo the key point is high throughput or deep sequencing for complete genome deduction. The answer should reflect that. I need to make sure to paraphrase correctly without adding extra info. The user wants a concise answer based on the context provided. No need to mention other studies unless they contradict, which they don't here. So the answer is clear.\n</think>\n\nMost of the analysis of MERS-CoV genetics has been performed using **high throughput or \"deep\" sequencing methods** for complete genome deduction. This approach has been central to studying the virus's genetic variation and global spread.",
      "retrieved_chunks": [
        "Title: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Most of the analysis of MERS-CoV genetics has been performed using high throughput or \"deep\" sequencing methods for complete genome deduction . MERS-CoV was the first subject of such widespread use of deep sequencing to study an emerging viral outbreak with global reach.",
        "Whole genome sequencing has been used extensively to study MERS-CoV travel and variation and although it remains a tool for experts, it appears\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Two studies during 2015, one looking at Jeddah-2014 MERS-CoV variants and another looking at a variant exported from South Korea to China, have now identified signs of genetic recombination among MERS-CoV variants.",
        "Despite assays having been published early on, subgenomic sequencing, once the mainstay of viral outbreak studies, has less often been published during MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Analyses of MERS-CoV genomes have shown that most single nucleotide differences among variants were located in the last third of the genome , which encodes the spike protein and accessory proteins . At least nine MERS-CoV genomes contained amino acid substitutions in the receptor binding domain of the spike protein and codons 158 , 460 , 1020 , 1202 and 1208 bear investigation as markers of adaptive change . The spike protein had not changed in the recombinant MERS-CoV genome identified in China in 2015 but was reported to have varied at a higher rate than that for complete MERS-CoV\n\nTitle: MERS coronavirus: diagnostics, epidemiology and transmission\nPassage: Vigilance remains important for containment since MERS-CoV is a virus with a genetic makeup that has been observed for only three years and is not stable.",
        "Continued laboratory testing, sequencing, analysis, timely data sharing and clear communication are essential for such vigilance to be effective.",
        "While human and camel whole genome sequences have retained >99 % identity with each other, members of genetically distinct lineages can and do swap genetic material when suitable conditions and coinfections co-occur ."
      ],
      "computed_relevance": 0.125,
      "computed_utilization": 0.125,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.2857142857142857,
      "gt_utilization": 0.047619047619047616,
      "gt_completeness": 0.16666666666666666,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 8,
      "dataset_id": "1129",
      "question": "How were  the spread of GFP-expressing virus-infected cells tracked?",
      "ground_truth_answer": "The spread of GFP-expressing virus-infected cells was tracked using immunofluorescence microscopy, whole-organ imaging with IVIS, flow cytometry, and inverted fluorescence microscopy.",
      "generated_response": "<think>\nOkay, let's see. The user is asking how the spread of GFP-expressing virus-infected cells was tracked. I need to look at the provided context and passages to find the answer.\n\nFirst, the context mentions that images show GFP-expressing cells in white and non-GFP in black. Then, looking at the first passage under the influenza A viruses title, it says that GFP was observable in the lungs of infected mice using IVIS for whole-organ imaging and also with flow cytometry to analyze infection progression in antigen-presenting cells. The imaging of murine lungs showed infection starting near large airways and spreading deeper.\n\nAnother passage mentions using an inverted fluorescence microscope to monitor plates after applying an overlay until GFP expression was seen. Also, there's mention of generating GFP-expressing cell clones via transduction and puromycin selection.\n\nSo, the main methods here seem to be IVIS for whole-organ imaging, flow cytometry for analyzing specific cell types, and fluorescence microscopy for observing cells in culture. The answer should combine these methods as the ways they tracked the spread. The user probably wants the specific techniques mentioned in the passages. Need to make sure not to include unrelated info like the MLV concentration or puromycin selection unless they directly relate to tracking spread. The key points are IVIS, flow cytometry, and fluorescence microscopy.\n</think>\n\nThe spread of GFP-expressing virus-infected cells was tracked using **whole-organ imaging with IVIS** (to observe GFP in lungs ex vivo), **flow cytometry** (to analyze infection progression in antigen-presenting cells), and **inverted fluorescence microscopy** (to monitor GFP expression in cell cultures over time). These methods allowed visualization of viral spread from initial infection sites (e.g., airways) to deeper lung regions and provided dynamic insights into infection dynamics.",
      "retrieved_chunks": [
        "One color channel was imaged, such that images produced show GFP-expressing cells in white and non-GFP-expressing cells in black .",
        "Although the approach to adoptively transfer fluorescent cells of interest into donor mice for functional imaging studies is fast and flexible,\n\nTitle: Replication-Competent Influenza A Viruses Expressing Reporter Genes\nPassage: lungs. Not only was GFP observable in the lungs of infected mice ex vivo using IVIS for whole-organ imaging, but could also be observed using flow cytometry to analyze the infection progression in antigen presenting cells . Imaging of murine lungs showed that infection starts in the respiratory tract in areas close to large conducting airways and later spreads to deeper sections of the lungs .",
        "Title: Illuminating the Sites of Enterovirus Replication in Living Cells by Using a Split-GFP-Tagged Viral Protein\nPassage: transduction, the MLV particles were 5 to 10 times concentrated using a 100-kDa concentrator .",
        "Title: Accelerated viral dynamics in bat cell lines, with implications for zoonotic emergence\nPassage: After application of the overlay, plates were monitored periodically using an inverted fluorescence microscope until the first signs of GFP expression were witnessed .",
        "For the generation of single-cell clones stably expressing GFP, BGM and HeLa cells were transduced and grown in the presence of puromycin to generate pools of GFP-expressing cells, which were subsequently used to prepare single-cell clones by limiting dilution."
      ],
      "computed_relevance": 0.42857142857142855,
      "computed_utilization": 0.42857142857142855,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.21052631578947367,
      "gt_utilization": 0.21052631578947367,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    },
    {
      "example_idx": 9,
      "dataset_id": "1261",
      "question": "What's the recommended procedure to disinfect at CT scanner after a COVID-19 exposure?",
      "ground_truth_answer": "The recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves sterilization procedures, noncontaminated CT disinfection procedures, and immediate disinfection of the imaging equipment after the examination.",
      "generated_response": "<think>\nOkay, let's see. The user is asking about the recommended procedure to disinfect a CT scanner after a COVID-19 exposure. The context provided has several passages with similar titles and mentions of CT disinfection procedures.\n\nFirst, I need to parse the context. The titles all mention \"The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\" and the passages talk about noncontaminated CT disinfection procedures after suspected cases, fever-CTs, and preparing to disinfect imaging equipment immediately after examination.\n\nThe key points here are that after examining a suspected COVID-19 case, the CT equipment needs to be disinfected. The passages mention \"immediately after the examination\" and \"sterilization procedures.\" The term \"noncontaminated CT disinfection procedures\" might be a bit confusing, but since they're talking about after the examination, it's likely referring to the steps taken to clean the equipment to prevent contamination.\n\nSince the answer should be based on the provided context, I need to make sure I don't add any external information. The context doesn't specify the exact steps (like which disinfectants to use or how long to wait), but it does emphasize that the disinfection should happen immediately after the examination. The answer should probably mention that the equipment is disinfected right after the exam, following sterilization procedures. The repetition of \"fever-CTs\" might indicate that these are specific types of CT scanners used for patients with fever, but the main point is the timing and the process of disinfection post-examination.\n\nSo the answer should state that the recommended procedure is to disinfect the CT scanner immediately after the examination using the specified sterilization procedures. The context doesn't go into more detail, so I shouldn't assume beyond that. I need to make sure the answer is concise and directly references the context provided.\n</think>\n\nThe recommended procedure to disinfect a CT scanner after a COVID-19 exposure involves **immediately disinfecting the imaging equipment following the examination** using established sterilization protocols. The context emphasizes that this process should occur right after the examination to prevent contamination, ensuring the equipment is properly prepared for subsequent use. Specific details about disinfectants or methods are not provided in the given passages, but the timing and urgency of the procedure are highlighted.",
      "retrieved_chunks": [
        "Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Noncontaminated CT disinfection procedures after suspected COVID-19 case examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: Fever-CT disinfection procedures after examination\n\nTitle: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: fever-CTs) after these sterilization procedures. Title: The Battle Against Coronavirus Disease 2019 (COVID-19): Emergency Management\nPassage: equipment and prepares to disinfect the imaging equipment immediately after the examination."
      ],
      "computed_relevance": 1.0,
      "computed_utilization": 1.0,
      "computed_completeness": 1.0,
      "computed_adherence": 1.0,
      "gt_relevance": 0.5,
      "gt_utilization": 0.5,
      "gt_completeness": 1.0,
      "gt_adherence": 1.0,
      "binary_pred": 1,
      "binary_gt": 1,
      "is_valid": true,
      "is_rate_limited": false,
      "is_skipped": false,
      "error": ""
    }
  ],
  "skipped_samples": []
}